Literature DB >> 15814907

Cerebral MR imaging in uninfected children born to HIV-seropositive mothers and perinatally exposed to zidovudine.

Marc Tardieu1, Francis Brunelle, Charles Raybaud, William Ball, Béatrice Barret, Brigitte Pautard, Eric Lachassine, Marie-Jeanne Mayaux, Stéphane Blanche.   

Abstract

BACKGROUND AND
PURPOSE: Mitochondrial dysfunction has been reported in HIV-negative children perinatally exposed to zidovudine, a drug often used in HIV-seropositive mothers during pregnancy. The purpose of this study was to determine the incidence of cerebral MR imaging findings in HIV-uninfected children exposed to zidovudine who present with unexplained neurologic symptoms.
METHODS: Two expert groups conducted a systematic, retrospective review of all cerebral MR images available in a multicentric, nationwide French prospective cohort of children born to HIV-seropositive mothers to identify imaging abnormalities. Experts were blinded to each others' interpretations, to the children's neurologic symptoms, and to laboratory evidence of mitochondrial dysfunction. The incidence of abnormalities was determined and compared with the neurologic presentation and laboratory evidence of mitochondrial dysfunction.
RESULTS: MR images from 49 HIV-uninfected children (mean age, 26 months) were available for study. All children were perinatally exposed to zidovudine. Twenty-two had probable or established mitochondrial dysfunction according to their symptoms and laboratory data. Twenty-seven children without mitochondrial dysfunction presented with unexplained neurologic symptoms (n = 14) or nonneurologic symptoms (n = 7), and six were asymptomatic. Sixteen of 22 MR images in children with mitochondriopathy were considered abnormal in both independent analyses. Diffuse hyperintensity in the supratentorial white matter (n = 9) and in the tegmentum pons (n = 9) were the most frequent anomalies. Imaging abnormalities were often multifocal (n = 10) and sometimes associated with necrotic areas (n = 3) and volume loss (n = 8). Although 19 of 27 MR images of children without mitochondrial dysfunction were mainly normal, abnormal images were observed in five of 14 children with unexplained neurologic symptoms and in three of six asymptomatic children.
CONCLUSION: Images observed in children with antiretroviral-induced mitochondrial dysfunction are similar to those observed in congenital mitochondrial diseases. These images were also observed in symptomatic or asymptomatic children without evidence of systemic mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814907      PMCID: PMC7977132     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  29 in total

1.  The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities.

Authors:  N Darin; A Oldfors; A R Moslemi; E Holme; M Tulinius
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

Review 2.  Statistical description of interrater variability in ordinal ratings.

Authors:  J C Nelson; M S Pepe
Journal:  Stat Methods Med Res       Date:  2000-10       Impact factor: 3.021

3.  Genotoxic and functional consequences of transplacental zidovudine exposure in fetal monkey brain mitochondria.

Authors:  E L Ewings; M Gerschenson; M C St Claire; K Nagashima; B Skopets; S W Harbaugh; J W Harbaugh; M C Poirier
Journal:  J Acquir Immune Defic Syndr       Date:  2000-06-01       Impact factor: 3.731

4.  Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients.

Authors:  A Muñoz; F Mateos; R Simón; M T García-Silva; S Cabello; J Arenas
Journal:  Neuroradiology       Date:  1999-12       Impact factor: 2.804

5.  Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.

Authors:  M Gerschenson; S W Erhart; C Y Paik; M C St Claire; K Nagashima; B Skopets; S W Harbaugh; J W Harbaugh; W Quan; M C Poirier
Journal:  AIDS Res Hum Retroviruses       Date:  2000-05-01       Impact factor: 2.205

6.  Leigh syndrome: serial MR imaging and clinical follow-up.

Authors:  J Arii; Y Tanabe
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

7.  Neuroradiologic findings in children with mitochondrial disorders.

Authors:  L Valanne; L Ketonen; A Majander; A Suomalainen; H Pihko
Journal:  AJNR Am J Neuroradiol       Date:  1998-02       Impact factor: 3.825

8.  Mitochondrial DNA depletion, near-fatal metabolic acidosis, and liver failure in an HIV-infected child treated with combination antiretroviral therapy.

Authors:  J A Church; W G Mitchell; I Gonzalez-Gomez; J Christensen; T H Vu; S Dimauro; R G Boles
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

9.  Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events.

Authors:  K Abe; H Yoshimura; H Tanaka; N Fujita; T Hikita; S Sakoda
Journal:  Neuroradiology       Date:  2003-12-12       Impact factor: 2.804

Review 10.  Clinical implications of CNS penetration of antiretroviral drugs.

Authors:  Heather E Wynn; Richard C Brundage; Courtney V Fletcher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

View more
  14 in total

Review 1.  Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection?

Authors:  Heather Carryl; Melanie Swang; Jerome Lawrence; Kimberly Curtis; Herman Kamboj; Koen K A Van Rompay; Kristina De Paris; Mark W Burke
Journal:  ACS Chem Neurosci       Date:  2015-06-19       Impact factor: 4.418

2.  Altered brain morphometry in 7-year old HIV-infected children on early ART.

Authors:  Emmanuel C Nwosu; Frances C Robertson; Martha J Holmes; Mark F Cotton; Els Dobbels; Francesca Little; Barbara Laughton; Andre van der Kouwe; Ernesta M Meintjes
Journal:  Metab Brain Dis       Date:  2017-12-05       Impact factor: 3.584

3.  Early Antiretroviral Therapy in HIV-Infected Children Is Associated with Diffuse White Matter Structural Abnormality and Corpus Callosum Sparing.

Authors:  C Ackermann; S Andronikou; M G Saleh; B Laughton; A A Alhamud; A van der Kouwe; M Kidd; M F Cotton; E M Meintjes
Journal:  AJNR Am J Neuroradiol       Date:  2016-08-18       Impact factor: 3.825

4.  Hearing Loss in Offspring Exposed to Antiretrovirals During Pregnancy and Breastfeeding.

Authors:  J Riley DeBacker; Breanna Langenek; Eric C Bielefeld
Journal:  Front Mol Neurosci       Date:  2022-06-20       Impact factor: 6.261

Review 5.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

6.  Effects of Zidovudine Treatment on Heart mRNA Expression and Mitochondrial DNA Copy Number Associated with Alterations in Deoxynucleoside Triphosphate Composition in a Neonatal Rat Model.

Authors:  Jacob W Snowdin; Chia-Heng Hsiung; Daniel G Kesterson; Vasudeva G Kamath; Edward E McKee
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

Review 7.  Evaluating Neurodevelopmental Consequences of Perinatal Exposure to Antiretroviral Drugs: Current Challenges and New Approaches.

Authors:  Jordan G Schnoll; Brian Temsamrit; Daniel Zhang; Hongjun Song; Guo-Li Ming; Kimberly M Christian
Journal:  J Neuroimmune Pharmacol       Date:  2019-09-11       Impact factor: 4.147

8.  Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.

Authors:  Carmen D Zorrilla; Vivian Tamayo-Agrait
Journal:  HIV AIDS (Auckl)       Date:  2009-12-08

9.  Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine.

Authors:  Anna Rita Zuena; Chiara Giuli; Aldina Venerosi Pesciolini; Antonella Tramutola; Maria Antonietta Ajmone-Cat; Carlo Cinque; Giovanni Sebastiano Alemà; Angela Giovine; Gianfranco Peluso; Luisa Minghetti; Raffaella Nicolai; Gemma Calamandrei; Paola Casolini
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART.

Authors:  Steven R Randall; Christopher M R Warton; Martha J Holmes; Mark F Cotton; Barbara Laughton; Andre J W van der Kouwe; Ernesta M Meintjes
Journal:  Front Neuroanat       Date:  2017-11-02       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.